Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 176.9 | 132.4 | 107.6 | 84.5 | 56.3 | 35.4 | 29.9 |
| Revenue growth | 33.6% | 23.1% | 27.3% | 50.0% | 59.0% | 18.5% | |
| Cost of goods sold | 54.0 | 48.1 | 37.8 | 30.7 | 23.6 | 0.0 | 0.0 |
| Gross profit | 122.9 | 84.3 | 69.8 | 53.8 | 32.8 | 35.4 | 29.9 |
| Gross margin | 69.5% | 63.7% | 64.9% | 63.6% | 58.2% | 100.0% | 100.0% |
| Selling, general and administrative | | | | | | 18.6 | 14.6 |
| Research and development | 5.2 | 3.4 | | 4.0 | | | |
| General and administrative | 6.8 | 4.1 | 3.4 | 2.9 | 4.1 | | |
| EBIT | 111.0 | 76.8 | 66.4 | 46.9 | 28.6 | 14.5 | 12.7 |
| EBIT margin | 62.7% | 58.0% | 61.7% | 55.5% | 50.8% | 41.0% | 42.4% |
| Pre-tax income | 89.6 | 57.9 | 44.1 | 36.8 | 23.6 | 8.1 | 6.8 |
| Income taxes | 29.0 | 18.5 | 13.9 | 11.2 | 11.2 | 3.0 | 2.6 |
| Tax rate | 32.4% | 31.9% | 31.6% | 30.5% | 47.5% | 37.8% | 37.5% |
| Net income | 60.6 | 39.5 | 30.1 | 25.6 | 12.4 | 5.0 | 4.3 |
| Net margin | 34.2% | 29.8% | 28.0% | 30.2% | 22.0% | 14.1% | 14.3% |
| |
| Diluted EPS | $6.53 | $4.70 | $3.61 | $3.08 | $2.38 | | |
| Shares outstanding (diluted) | 9.3 | 8.4 | 8.3 | 8.3 | 5.2 | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|